Kurser indlæses...

Prognose

Analytikernes gennemsnitlige kursmål er 111,27 € (+6,05 %). Medianen er 109,45 € (+4,32 %).

Køb
  10
Behold
  14
Sælg
  2

Diskussioner i communityet

Der er endnu ingen diskussion om dette aktiv.

Start diskussion

  • agilon health raises EBITDA forecast: turnaround driven by contract discipline and clinical programs

    At the Jefferies conference, agilon health said the shift from growth to profitability is showing initial success and raised its 2026 EBITDA forecast to $75–95 million. Improved contract terms, a new data pipeline, tighter cost control and advanced clinical programs—especially for heart failure—contributed to better risk-adjusted and cost outcomes. The company closed Q2 with $257 million in cash (excluding ACO units) and expects at least $125 million by year-end, but remains cautious due to medical cost sensitivity to small variances. » Mere på de.investing.com


  • Agilon Health significantly beats Q2 expectations and raises full‑year outlook

    Agilon Health reported adjusted earnings of $1.04 per share in Q2 2026 (expectation $0.08) and revenue of $1.49 billion (expectation $1.44 billion), and subsequently raised its full‑year guidance for revenue, medical margin and adjusted EBITDA. The medical margin rose to $197 million and adjusted EBITDA to $70 million, despite a deliberate 12.3% reduction in Medicare Advantage membership. Management attributes the strong results to stricter contract discipline, improved risk adjustments and favorable cost trends. The stock jumped sharply and the company now expects about $5.8 billion in revenue and roughly $85 million of adjusted EBITDA for 2026. » Mere på de.investing.com

Virksomhedstal

I det seneste kvartal havde Agilon Health Inc en omsætning på 1,34 mia. € og et nettoresultat på 30,82 mio. €
(EUR) september 2026
YoY
Omsætning 1,34 mia. 9,68 %
Bruttofortjeneste 86,5 mio. 250,07 %
Nettoresultat 30,82 mio. 132,82 %
EBITDA 41,84 mio. 148,49 %

Fundamentale data

Nøgletal Værdi
Markedsværdi
1,76 mia. €
Antal aktier
16,8 mio.
Højeste/laveste i 52 uger
120,84 € - 6,79 €
Udbytte Nej
Beta
3,11
P/E (PE Ratio)
-17,66
PEG (PEG Ratio)
-0,30
K/I (PB Ratio)
6,92
P/S (PS Ratio)
0,32

Virksomhedsprofil

Navn
Agilon Health Inc
CEO
Timothy O'Rourke
Medarbejdere 856
🍪

Parqet  bruger cookies. Læs mere